Previous portfolio manager for 505(b)(2) division of Teva Pharmaceuticals 15+ yrs experience managing LAI development programs.
Mark Hasleton
Co-Founder & Chief Executive Officer
Pharmacy and Pathology at Maudsley Hospital. Current member of the UK government’s Advisory Council on Misuse of Drugs.
Prof. David Taylor
Co-Founder and Scientific Advisor
Former Chief Scientific Officer of Medincell for nine years, vast expertise with micro-particle and hydrogel LAI formulations.
Georges Gaudriault
Formulation Lead
15 yrs experience in leading preclinical development for pharma and biotech PhD in neuropharmacology.
Johanna Schumann
Pre Clinical Lead
Previous Healthcare Private Equity (Bridgepoint) and Director Investments EHC , Business Admin. WHU Otto Beisheim School of Management.
Chief Financial Officer
Sofia Weirich
Currently CEO of Mineralys Therapeutics Inc. Previously >14 years at Teva with vast commercial experience
Board Member
Jon Congleton
Former Senior Partner McKinsey & Company leading European Pharma and Healthcare Private Equity practice. Trained doctor.